Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ISABELLE AYOUB

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1669617221
CMS profile
1328098
Location
COLUMBUS, OH

General Payments · PY2018–2024

$59,729.44

  • Reported across 71 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$33,982.19

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
F. Hoffmann-La Roche AG $15,980.86 5
Otsuka Pharmaceutical Development & Commercialization, Inc. $10,037.50 4
Retrophin, Inc. $3,571.60 8
CALLIDITAS THERAPEUTICS US INC. $3,228.76 3
GlaxoSmithKline, LLC. $1,038.71 7
Amgen Inc. $124.76 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $6,882.22 10
PY2019 $540.63 2
PY2022 $283.04 5
PY2023 $18,041.36 26
PY2024 $33,982.19 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $124.76 05/15/2024 Food and Beverage Undisputed 01/23/2026 1117194390 CMS
CALLIDITAS THERAPEUTICS US INC. $104.26 04/12/2024 Food and Beverage Undisputed 01/23/2026 1141513215 CMS
CALLIDITAS THERAPEUTICS US INC. $3,000.00 07/26/2024 Consulting Fee Undisputed 01/23/2026 1141519337 CMS
CALLIDITAS THERAPEUTICS US INC. $124.50 07/26/2024 Travel and Lodging Undisputed 01/23/2026 1141519339 CMS
F. Hoffmann-La Roche AG $5,190.00 05/24/2024 Consulting Fee Undisputed 01/23/2026 1133022721 CMS
F. Hoffmann-La Roche AG $925.50 05/24/2024 Travel and Lodging Undisputed 01/23/2026 1133022726 CMS
F. Hoffmann-La Roche AG $1,623.69 05/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133022730 CMS
F. Hoffmann-La Roche AG $118.24 05/24/2024 Travel and Lodging Undisputed 01/23/2026 1133022734 CMS
F. Hoffmann-La Roche AG $8,123.43 05/24/2024 Travel and Lodging Undisputed 01/23/2026 1133022738 CMS
GlaxoSmithKline, LLC. $548.39 12/02/2024 Travel and Lodging Undisputed 01/23/2026 1115914594 CMS
GlaxoSmithKline, LLC. $31.02 12/02/2024 Travel and Lodging Undisputed 01/23/2026 1116280211 CMS
GlaxoSmithKline, LLC. $272.46 12/06/2024 Travel and Lodging Undisputed 01/23/2026 1116601087 CMS
GlaxoSmithKline, LLC. $19.88 12/07/2024 Food and Beverage Undisputed 01/23/2026 1116061580 CMS
GlaxoSmithKline, LLC. $64.93 12/07/2024 Food and Beverage Undisputed 01/23/2026 1116070450 CMS
GlaxoSmithKline, LLC. $46.38 12/07/2024 Food and Beverage Undisputed 01/23/2026 1116292845 CMS
GlaxoSmithKline, LLC. $55.65 12/07/2024 Food and Beverage Undisputed 01/23/2026 1116553703 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $1,460.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 1118835433 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $3,467.50 07/22/2024 Consulting Fee Undisputed 01/23/2026 1118835435 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $2,190.00 10/24/2024 Consulting Fee Undisputed 01/23/2026 1118835437 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $2,920.00 12/03/2024 Consulting Fee Undisputed 01/23/2026 1118835439 CMS
Travere Therapeutics, Inc. $3.08 05/07/2024 Education Undisputed 01/23/2026 1149875853 CMS
Travere Therapeutics, Inc. $104.65 05/16/2024 Food and Beverage Undisputed 01/23/2026 1149875865 CMS
Travere Therapeutics, Inc. $73.43 05/24/2024 Food and Beverage Undisputed 01/23/2026 1149875877 CMS
Travere Therapeutics, Inc. $2,500.00 05/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1149875881 CMS
Travere Therapeutics, Inc. $555.95 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1149875873 CMS
Travere Therapeutics, Inc. $227.36 09/21/2024 Travel and Lodging Undisputed 01/23/2026 1149875869 CMS
Travere Therapeutics, Inc. $3.08 10/01/2024 Education Undisputed 01/23/2026 1149875857 CMS
Travere Therapeutics, Inc. $104.05 11/06/2024 Food and Beverage Undisputed 01/23/2026 1149875861 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.